| The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research N Percie du Sert, V Hurst, A Ahluwalia, S Alam, MT Avey, M Baker, ... Journal of Cerebral Blood Flow & Metabolism 40 (9), 1769-1777, 2020 | 4848 | 2020 |
| A manifesto for reproducible science MR Munafò, BA Nosek, DVM Bishop, KS Button, CD Chambers, ... Nature human behaviour 1 (1), 1-9, 2017 | 2865 | 2017 |
| Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0 NP Du Sert, A Ahluwalia, S Alam, MT Avey, M Baker, WJ Browne, A Clark, ... PLoS biology 18 (7), e3000411, 2020 | 1466 | 2020 |
| Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain N Percie du Sert, ASC Rice British journal of pharmacology 171 (12), 2951-2963, 2014 | 210 | 2014 |
| The IMPROVE guidelines (ischaemia models: procedural refinements of in vivo experiments) N Percie du Sert, A Alfieri, SM Allan, HVO Carswell, GA Deuchar, TD Farr, ... Journal of Cerebral Blood Flow & Metabolism 37 (11), 3488-3517, 2017 | 151 | 2017 |
| The experimental design assistant N Percie du Sert, I Bamsey, ST Bate, M Berdoy, RA Clark, I Cuthill, D Fry, ... PLoS biology 15 (9), e2003779, 2017 | 105 | 2017 |
| Ware, and John PA Ioannidis. 2017.“A manifesto for reproducible science.” MR Munafò, BA Nosek, DVM Bishop, KS Button, CD Chambers, ... Nature human behaviour 1 (1), 21, 0 | 90 | |
| Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists N Percie du Sert, JA Rudd, CC Apfel, PLR Andrews Cancer chemotherapy and pharmacology 67, 667-686, 2011 | 75 | 2011 |
| A manifesto for reproducible science. Nature Human Behaviour, 1 (1), 1–9 MR Munafò, BA Nosek, DV Bishop, KS Button, CD Chambers, NP Du Sert, ... | 53 | 2017 |
| Predicting the emetic liability of novel chemical entities: a comparative study NP du Sert, AM Holmes, R Wallis, PLR Andrews British journal of pharmacology 165 (6), 1848-1867, 2012 | 49 | 2012 |
| Revision of the ARRIVE guidelines: rationale and scope NP Du Sert, V Hurst, A Ahluwalia, S Alam, DG Altman, MT Avey, M Baker, ... BMJ open science 2 (1), 2018 | 48 | 2018 |
| General principles of preclinical study design W Huang, N Percie du Sert, J Vollert, ASC Rice Good research practice in non-clinical pharmacology and biomedicine, 55-69, 2020 | 37 | 2020 |
| Telemetry in a motion‐sickness model implicates the abdominal vagus in motion‐induced gastric dysrhythmia N Percie du Sert, KM Chu, MK Wai, JA Rudd, PLR Andrews Experimental physiology 95 (7), 768-773, 2010 | 37 | 2010 |
| A manifesto for reproducible science. Nature Human Behaviour, 1, 0021 MR Munafò, BA Nosek, DV Bishop, KS Button, CD Chambers, NP du Sert, ... | 36 | 2017 |
| Reduced normogastric electrical activity associated with emesis: a telemetric study in ferrets NP du Sert, KM Chu, MK Wai, JA Rudd, PLR Andrews World Journal of Gastroenterology: WJG 15 (48), 6034, 2009 | 33 | 2009 |
| The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret NP du Sert, JA Rudd, R Moss, PLR Andrews Neuroscience letters 465 (1), 16-20, 2009 | 33 | 2009 |
| Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret KM Chu, MP Ngan, MK Wai, CK Yeung, PLR Andrews, NP du Sert, ... Neuropharmacology 58 (2), 383-391, 2010 | 24 | 2010 |
| Framework for advancing rigorous research WJ Koroshetz, S Behrman, CJ Brame, JL Branchaw, EN Brown, EA Clark, ... Elife 9, e55915, 2020 | 20 | 2020 |
| Maximising the output of osteoarthritis research: the ARRIVE guidelines NP du Sert Osteoarthritis and cartilage 20 (4), 253-255, 2012 | 20 | 2012 |
| Wytyczne ARRIVE 2.0: Zaktualizowane wytyczne dotyczące raportowania badań na zwierzętach NP Du Sert, V Hurst, A Ahluwalia, S Alam, MT Avey, M Baker, WJ Browne, ... PLos Biol. 18, e3000410, 2020 | 17 | 2020 |
